T1	intervention 10 31	myofascial techniques
T2	location 402 409	Belgium
T3	total-participants 422 424	50
T4	eligibility 425 516	patients with persistent arm pain and myofascial dysfunctions after breast cancer treatment
T5	control 721 736	placebo therapy
T7	outcome 1158 1172	pain intensity
T11	iv-bin-percent 1381 1384	44%
T12	cv-bin-percent 1392 1395	64%
T13	condition 49 68	persistent arm pain
T6	outcome-Measure 767 781	pain intensity
T8	outcome-Measure 847 874	prevalence rate of arm pain
T9	outcome-Measure 876 901	pressure hypersensitivity
T14	outcome-Measure 941 953	pain quality
T10	outcome 1408 1430	still experienced pain
